Industry News

3 Ways Pharmacy Benefit Programs Can Prepare for Biosimilar Drugs

By understanding your contract, communicating with your PBM, and working with a partner to craft your pharmacy strategy, you’ll be well prepared for the rise of biosimilar drugs.

Learn more →

The Accumulator Adjustment Ruling of 2023 – What’s Next for Brands

On May 17, 2022, the U.S. District Court for DC ruled against the “accumulator adjustment rule.” What impact will this have on pharma?

Learn more →

6 Takeaways from the Asembia 2022 Specialty Pharmacy Summit

6,000 pharmacy professionals attended Asembia this year. What were the key takeaways from the conference?

Learn more →

Asembia 2021: Four Key Takeaways

Four core themes from Asembia 2021 that will drive dialogue in the specialty pharmacy ecosystem in 2022 – and beyond.

Learn more →

The Impact of COVID-19 on Brand Prescribing and Claims

Read Truveris’ data report on the impact of COVID-19 on pharma, specifically prescribing and claims numbers for branded drugs.

Learn more →

Podcast - The Future of the PBM Landscape

What is the future of the PBM landscape? Listen to Truveris CEO, Nanette Oddo, opine on the shifts she’s seeing in the pharmacy ecosystem.

Learn more →

Truveris Appoints Nanette Oddo President and Chief Executive Officer

Truveris announced today that Nanette Oddo, formerly Truveris’ Chief Strategy Officer, has been named President and Chief Executive Officer.

Learn more →

Industry Update: The Impact of State Legislation on Copay Accumulator Programs

Several states have passed legislation that prohibits the use of copay accumulator adjustment programs. How does this affect your organization?

Learn more →

Anthem to Transition Members to IngenioRx PBM 10 Months Sooner Than Expected

In October of 2017, Anthem Inc. announced its launching of IngenioRx, an in-house pharmacy benefits manager (PBM).

Learn more →